Although these insights have not yet yielded clinically established interventions comparable to acetylcholinesterase inhibitors in Alzheimer’s disease or SSRIs in depression, progress in this field continues to refine our understanding of early pathological changes. This evidence concerns the gene ACHE and Alzheimer disease.